...
首页> 外文期刊>Investigative radiology >Computed Tomography for 4-Dimensional Angiography and Perfusion Imaging of the Prostate for Embolization Planning of Benign Prostatic Hyperplasia.
【24h】

Computed Tomography for 4-Dimensional Angiography and Perfusion Imaging of the Prostate for Embolization Planning of Benign Prostatic Hyperplasia.

机译:用于良性前列腺增生的前列腺前列腺的4维血管造影和灌注成像的计算机断层扫描。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The aim of this study was to evaluate the feasibility of a computed tomography (CT) protocol enabling the visualization of the prostatic artery (PA) before prostatic artery embolization (PAE) in benign prostatic hyperplasia, which provides quantitative perfusion information of the prostate gland. In this institutional review board-approved study, 22 consecutive patients (mean age, 67 ± 7 years) who were planned to undergo PAE underwent a dynamic CT scan of the pelvis (scan range, 22.4 cm; cycle time, 1.5 seconds; scan time, 44 seconds; 25 scan cycles; 70 kVp; 100 mAs) after the administration of 70 mL of iodinated contrast media (flow rate, 6 mL/s; 10 seconds' delay). Image postprocessing consisted of a spatiotemporal, frequency-depending multiband filtering technique with noise reduction, motion correction, resulting in (1) time-resolved, temporal maximum intensity projection (MIP) images from fusion of multiple arterial time points; (2) 4-dimensional (4D) CT angiography images after bone and calcium plaque removal; and (3) parametric perfusion maps of the prostate. Intraprocedural cone-beam CT was performed with a microcatheter in the PA. In both modalities, the contrast-to-noise ratio of the right internal iliac artery or the PA was calculated, respectively. Visibility of the PA was scored using a Likert scale (score 1 = not seen, to score 4 = intraprostatic PA branches seen). Quantitative perfusion analysis of the dynamic pelvic CT included calculation of the blood flow, blood volume, mean transit time, and flow extraction product. The average volume CT dose index and dose length product of CT was 35.7 ± 6.8 mGy and 737.4 ± 146.3 mGy·cm, respectively. Contrast-to-noise ratio of the pelvic vessels on temporal MIP images and cone-beam CT were 45 ± 19 and 69 ± 27, respectively (P < 0.01). The mean visibility score of the PA was 3.6 ± 0.6 for 4D-CT angiography and 3.97 ± 0.2 for cone-beam CT (P < 0.001). The PA was visualized in 100% of 4D-CT angiography examinations, with one PA being visible only proximally. Prostate CT perfusion analysis showed blood flow, blood volume, mean transit time, and flow extraction product values of 27.9 ± 12.5 mL/100 mL/min, 2.0 ± 0.8 mL/100 mL, 4.5 ± 0.5 second, and 12.6 ± 5.4 mL/100 mL/min, respectively, for the whole prostate gland. About half the patients showed a pronounced difference between the lobes. We introduced a CT protocol for PAE planning providing excellent visualization of the PA on temporal MIP images and 4D-CT angiography at a reasonable dose and low contrast volume. In addition, quantitative perfusion information is available, which might be useful for outcome prediction after embolization.
机译:本研究的目的是评估计算机断层扫描(CT)协议的可行性,使前列腺动脉栓塞(PAE)在良性前列腺增生前的前列腺动脉(PA)的可视化,这提供了前列腺的定量灌注信息。在这一制度审查委员会批准的研究中,计划经历PELVIS的动态CT扫描(扫描范围,22.4厘米;循环时间,1.5秒;循环时间,1.5秒;循环时间,122例患者(平均年龄,67±7岁)的连续患者(平均年龄,67±7岁)进行了动态CT扫描,44秒; 25次扫描循环; 70 kVp; 100 mas)施用70ml碘化造影剂(流速,6ml / s; 10秒'延迟)。图像后处理包括时空,频率依赖的多频带过滤技术,具有降噪,运动校正,导致(1)时间分辨,时间最大强度投影(MIP)图像来自多个动脉时间点的融合; (2)4维(4D)CT血管造影骨骨和钙牙菌斑的去除; (3)前列腺的参数灌注图。在PA中用微直接计进行颅内锥梁CT。在两种方式中,分别计算右内髂动脉或PA的对比度。使用李克特量表的评分PA的可见度(得分1 =未看到,得分4 =看到的introdrostatic PA分支)。动态骨盆CT的定量灌注分析包括血流,血液体积,平均转动时间和流动提取产品的计算。 CT的平均体积CT剂量指数和剂量长度分别为35.7±6.8米,分别为737.4±146.3米米·厘米。盆腔图像上的骨盆血管和锥形梁CT上的对比度分别为45±19和69±27(P <0.01)。 4D-CT血管造影的PA的平均可见度得分为3.6±0.6,锥形束CT为3.97±0.2(P <0.001)。 PA在100%的4D-CT血管造影检查中可视化,只有一个PA仅在近端可见。前列腺CT灌注分析显示出血流量,血液体积,平均转动时间和流量提取产品值为27.9±12.5ml / 100ml / min,2.0±0.8ml / 100ml,4.5±0.5秒,12.6±5.4 ml /为整个前列腺100毫升/分钟分别为整个前列腺。大约一半的患者在裂片之间显示出明显的差异。我们介绍了一种CT协议,用于PAE规划,在合理的剂量和低对比度的情况下,在时间MIP图像和4D-CT血管造影上提供优异的PA可视化。此外,可提供定量灌注信息,这可能对栓塞后的结果预测有用。

著录项

  • 来源
    《Investigative radiology》 |2019年第10期|共8页
  • 作者单位

    From the Institute of Diagnostic and Interventional Radiology University Hospital Zurich Zurich;

    From the Institute of Diagnostic and Interventional Radiology University Hospital Zurich Zurich;

    Siemens Healthineers Forcheim Germany;

    From the Institute of Diagnostic and Interventional Radiology University Hospital Zurich Zurich;

    From the Institute of Diagnostic and Interventional Radiology University Hospital Zurich Zurich;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 放射医学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号